Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

300363 Porton Pharma Solutions

47.790
+0.810+1.72%
Trading Session 09/29 13:02 CCT
High
48.960
Open
47.980
Turnover
263.04M
Low
47.020
Pre Close
46.980
Volume
54.57K
Market Cap
26.00B
P/E(TTM)
17.09
52wk High
106.517
Shares
544.12M
P/E(Static)
49.63
52wk Low
46.350
Float Cap
21.63B
Bid/Ask %
-23.87%
Historical High
109.577
Shs Float
452.61M
Volume Ratio
1.46
Historical Low
6.575
Dividend TTM
0.193
Div Yield TTM
--
P/B
5.07
Dividend LFY
0.40%
Div Yield LFY
--
Turnover Ratio
1.21%
Amplitude
4.13%
Avg Price
48.206
Lot Size
100
Float Cap
21.63B
Bid/Ask %
-23.87%
Historical High
109.577
Shs Float
452.61M
Volume Ratio
1.46
Historical Low
6.575
Dividend TTM
0.193
Limit Up
56.380
P/B
5.07
Dividend LFY
0.40%
Limit Down
37.580
Turnover Ratio
1.21%
Amplitude
4.13%
Avg Price
48.206
Lot Size
100
Ask
22.55Klots
Bid
25.75Klots
Price Forecast

No Data

News

Comment

Company Overview More
Founded in July 2005, the company is headquartered in Chongqing, China, with subsidiaries in Chengdu, Shanghai, Yichun, Jiangxi, Hong Kong, Belgium, Switzerland and the United States. It is a high-tech enterprise that provides customized pharmaceutical R & D and production services for multinational pharmaceutical companies and biopharmaceutical companies in accordance with international standards. Boteng shares were listed on the gem of Shenzhen Stock Exchange on January 29th, 2014, stock code 300363. The company is mainly committed to providing global pharmaceutical companies and new drug R & D institutions with customized R & D and production services for chemical raw materials, chemical preparations and biological drugs from preclinical to clinical trials to the whole life cycle of drug marketing. The company's main businesses include chemical API CDMO business (including intermediates), chemical preparation CDMO business and biological CDMO business (including gene therapy and cell therapy). Corporate Honor: Chongqing Boteng Pharmaceutical Technology Co., Ltd. ranked 130th in the 2019 China CSR Top 500 list released on January 11, 2020.
CEO: --
Market: --
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...